Basit öğe kaydını göster

dc.contributor.authorPUNZI, Giuseppe
dc.contributor.authorSaygili, SEHA KAMİL
dc.contributor.authorTiryakioglu, N. Ozan
dc.contributor.authorONAL, Hasan
dc.contributor.authorPalmieri, Ferdinando
dc.contributor.authorTunali, Nagehan Ersoy
dc.contributor.authorMAROBBIO, Carlo M. T.
dc.date.accessioned2021-03-04T11:35:29Z
dc.date.available2021-03-04T11:35:29Z
dc.date.issued2014
dc.identifier.citationTunali N. E. , MAROBBIO C. M. T. , Tiryakioglu N. O. , PUNZI G., Saygili S. K. , ONAL H., Palmieri F., "A novel mutation in the SLC25A15 gene in a Turkish patient with HHH syndrome: Functional analysis of the mutant protein", MOLECULAR GENETICS AND METABOLISM, cilt.112, sa.1, ss.25-29, 2014
dc.identifier.issn1096-7192
dc.identifier.othervv_1032021
dc.identifier.otherav_7313b0e9-15b2-42a8-b646-e3c9e7687324
dc.identifier.urihttp://hdl.handle.net/20.500.12627/79178
dc.identifier.urihttps://doi.org/10.1016/j.ymgme.2014.03.002
dc.description.abstractThe hyperornithinemia-hyperammonemia-homocitrullinuria syndrome is a rare autosomal recessive disorder caused by the functional deficiency of the mitochondrial ornithine transporter 1 (ORC1). ORC1 is encoded by the SLC25A15 gene and catalyzes the transport of cytosolic ornithine into mitochondria in exchange for citrulline. Although the age of onset and the severity of the symptoms vary widely, the disease usually manifests in early infancy. The typical clinical features include protein intolerance, lethargy, episodic confusion, cerebellar ataxia, seizures and mental retardation. In this study, we identified a novel p.Ala15Val (c.44C > T) mutation by genomic DNA sequencing in a Turkish child presenting severe tantrum, confusion, gait disturbances and loss of speech abilities in addition to hyperornithinemia, hyperammonemia and homocitrullinuria. One hundred Turkish control chromosomes did not possess this variant. The functional effect of the novel mutation was assessed by both complementation of the yeast ORT1 null mutant and transport assays. Our study demonstrates that the A15V mutation dramatically interferes with the transport properties of ORC1 since it was shown to inhibit ornithine transport nearly completely. (C) 2014 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).
dc.language.isoeng
dc.subjectSağlık Bilimleri
dc.subjectDahili Tıp Bilimleri
dc.subjectİç Hastalıkları
dc.subjectEndokrinoloji ve Metabolizma Hastalıkları
dc.subjectTıbbi Genetik
dc.subjectTıbbi Ekoloji ve Hidroklimatoloji
dc.subjectYaşam Bilimleri
dc.subjectMoleküler Biyoloji ve Genetik
dc.subjectTemel Bilimler
dc.subjectYaşam Bilimleri (LIFE)
dc.subjectTIP, ARAŞTIRMA VE DENEYSEL
dc.subjectTıp
dc.subjectMoleküler Biyoloji ve Genetik
dc.subjectGENETİK VE HAYAT
dc.subjectKlinik Tıp (MED)
dc.subjectKlinik Tıp
dc.subjectENDOKRİNOLOJİ VE METABOLİZMA
dc.titleA novel mutation in the SLC25A15 gene in a Turkish patient with HHH syndrome: Functional analysis of the mutant protein
dc.typeMakale
dc.relation.journalMOLECULAR GENETICS AND METABOLISM
dc.contributor.departmentHaliç Üniversitesi , ,
dc.identifier.volume112
dc.identifier.issue1
dc.identifier.startpage25
dc.identifier.endpage29
dc.contributor.firstauthorID89273


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster